David E. Malarkey

5.1k total citations
102 papers, 3.5k citations indexed

About

David E. Malarkey is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David E. Malarkey has authored 102 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Cancer Research, 20 papers in Molecular Biology and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David E. Malarkey's work include Carcinogens and Genotoxicity Assessment (24 papers), Toxic Organic Pollutants Impact (12 papers) and Veterinary Oncology Research (11 papers). David E. Malarkey is often cited by papers focused on Carcinogens and Genotoxicity Assessment (24 papers), Toxic Organic Pollutants Impact (12 papers) and Veterinary Oncology Research (11 papers). David E. Malarkey collaborates with scholars based in United States, Israel and Germany. David E. Malarkey's co-authors include Robert R. Maronpot, Abraham Nyska, Gary A. Boorman, Bruce W. Keene, Grace E. Kissling, Thomas Nolte, Wolfgang Kaufmann, Takanori Harada, Karin Küttler and Donald Ε. Thrall and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Environmental Health Perspectives.

In The Last Decade

David E. Malarkey

101 papers receiving 3.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
David E. Malarkey 941 550 482 462 408 102 3.5k
Gordon C. Hard 1.3k 1.4× 456 0.8× 1.1k 2.3× 338 0.7× 205 0.5× 134 3.8k
Michael Bartels 439 0.5× 900 1.6× 527 1.1× 198 0.4× 474 1.2× 161 3.2k
Wanda M. Haschek 972 1.0× 404 0.7× 389 0.8× 676 1.5× 147 0.4× 122 4.4k
Paula A. Oliveira 1.6k 1.7× 228 0.4× 563 1.2× 410 0.9× 327 0.8× 252 4.0k
Gary P. Carlson 609 0.6× 539 1.0× 643 1.3× 334 0.7× 168 0.4× 183 3.6k
Thomas Nolte 519 0.6× 263 0.5× 285 0.6× 261 0.6× 149 0.4× 60 2.2k
John R. Latendresse 930 1.0× 698 1.3× 523 1.1× 109 0.2× 498 1.2× 92 3.6k
Walter Pfaller 1.4k 1.5× 393 0.7× 203 0.4× 435 0.9× 151 0.4× 123 3.5k
June K. Dunnick 835 0.9× 720 1.3× 574 1.2× 157 0.3× 271 0.7× 114 2.9k
Christer Tagesson 1.7k 1.8× 480 0.9× 669 1.4× 790 1.7× 557 1.4× 185 5.7k

Countries citing papers authored by David E. Malarkey

Since Specialization
Citations

This map shows the geographic impact of David E. Malarkey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Malarkey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Malarkey more than expected).

Fields of papers citing papers by David E. Malarkey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Malarkey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Malarkey. The network helps show where David E. Malarkey may publish in the future.

Co-authorship network of co-authors of David E. Malarkey

This figure shows the co-authorship network connecting the top 25 collaborators of David E. Malarkey. A scholar is included among the top collaborators of David E. Malarkey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David E. Malarkey. David E. Malarkey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shockley, Keith R., David E. Malarkey, Andrew D. Miller, et al.. (2022). Inter‐pathologist agreement on diagnosis, classification and grading of canine glioma. Veterinary and Comparative Oncology. 20(4). 881–889. 8 indexed citations
2.
Frawley, Rachel P., Kristine L. Witt, Helen Cunny, et al.. (2020). Evaluation of 2-methoxy-4-nitroaniline (MNA) in hypersensitivity, 14-day subacute, reproductive, and genotoxicity studies. Toxicology. 441. 152474–152474. 2 indexed citations
3.
Shockley, Keith R., Michelle Cora, David E. Malarkey, et al.. (2020). Comparative toxicity and liver transcriptomics of legacy and emerging brominated flame retardants following 5-day exposure in the rat. Toxicology Letters. 332. 222–234. 19 indexed citations
4.
Arao, Yukitomo, Katherine J. Hamilton, David E. Malarkey, et al.. (2017). Hormone signaling and fatty liver in females: analysis of estrogen receptor α mutant mice. International Journal of Obesity. 41(6). 945–954. 72 indexed citations
5.
Thoolen, Bob, Fiebo J.W. ten Kate, P. J. van Diest, et al.. (2012). Comparative Histomorphological Review of Rat and Human Hepatocellular Proliferative Lesions. Journal of Toxicologic Pathology. 25(3). 189–199. 33 indexed citations
6.
Stanko, Jason P., Jennifer L. Rayner, Christine Davis, et al.. (2010). Effects of prenatal exposure to a low dose atrazine metabolite mixture on pubertal timing and prostate development of male Long-Evans rats. Reproductive Toxicology. 30(4). 540–549. 41 indexed citations
7.
8.
Stout, Matthew D., Ronald A. Herbert, Grace E. Kissling, et al.. (2008). Hexavalent Chromium Is Carcinogenic to F344/N Rats and B6C3F1 Mice after Chronic Oral Exposure. Environmental Health Perspectives. 117(5). 716–722. 163 indexed citations
9.
Hardisty, Jerry F., Michael R. Elwell, Heinrich Ernst, et al.. (2007). Histopathology Of Hemangiosarcomas in Mice and Hamsters and Liposarcomas/Fibrosarcomas in Rats Associated with PPAR Agonists. Toxicologic Pathology. 35(7). 928–941. 32 indexed citations
10.
Bushel, Pierre R., Alexandra N. Heinloth, Lingkang Huang, et al.. (2007). Blood gene expression signatures predict exposure levels. Proceedings of the National Academy of Sciences. 104(46). 18211–18216. 90 indexed citations
11.
Walker, Dale M., David E. Malarkey, Steven K. Seilkop, et al.. (2007). Transplacental carcinogenicity of 3′‐azido‐3′‐deoxythymidine in B6C3F1 mice and F344 rats. Environmental and Molecular Mutagenesis. 48(3-4). 283–298. 30 indexed citations
12.
Malarkey, David E., et al.. (2006). Epidermal growth factor receptor expression in feline oral squamous cell carcinomas. Veterinary and Comparative Oncology. 4(1). 33–40. 30 indexed citations
13.
Dang, Hong, Carol S. Trempus, David E. Malarkey, et al.. (2005). Identification of genes and gene ontology processes critical to skin papilloma development in Tg.AC transgenic mice. Molecular Carcinogenesis. 45(2). 126–140. 7 indexed citations
14.
Baty, Catherine J., David E. Malarkey, Clarke E. Atkins, et al.. (2001). Natural History of Hypertrophic Cardiomyopathy and Aortic Thromboembolism in a Family of Domestic Shorthair Cats. Journal of Veterinary Internal Medicine. 15(6). 595–599. 27 indexed citations
15.
Baty, Catherine J., David E. Malarkey, Clarke E. Atkins, et al.. (2001). Natural History of Hypertrophic Cardiomyopathy and Aortic Thromboembolism in a Family of Domestic Shorthair Cats. Journal of Veterinary Internal Medicine. 15(6). 595–595. 29 indexed citations
16.
Trempus, Carol S., Sandra Ward, Georgia M. Farris, et al.. (1998). Association of v-Ha-ras Transgene Expression with Development of Erythroleukemia in Tg.AC Transgenic Mice. American Journal Of Pathology. 153(1). 247–254. 14 indexed citations
17.
Hardie, Elizabeth M., Shelly L. Vaden, Kathy A. Spaulding, & David E. Malarkey. (1995). Splenic Infarction in 16 Dogs: A Retrospective Study. Journal of Veterinary Internal Medicine. 9(3). 141–148. 30 indexed citations
18.
Malarkey, David E., Theodora R. Devereux, Gregg E. Dinse, Peter C. Mann, & Robert R. Maronpot. (1995). Hepatocarcinogenicity of chlordane in B6C3F1 and B6D2F1 male mice: evidence for regression in B6C3F1 mice and carcinogenesis independent of ras proto-oncogene activation. Carcinogenesis. 16(11). 2617–2625. 26 indexed citations
19.
Watson, Mary Ann, Theodora R. Devereux, David E. Malarkey, Marshall W. Anderson, & Robert R. Maronpot. (1995). H-ras oncogene mutation spectra in B6C3F1 and C57BL/6 mouse liver tumors provide evidence for TCDD promotion of spontaneous and vinyl carbamate-initiated liver cells. Carcinogenesis. 16(8). 1705–1710. 33 indexed citations
20.
Anna, Colleen H., et al.. (1994). ras proto-oncogene activation in dichloroacetic add-, trichloroethylene- and tetrachloroethylene-induced liver tumors in B6C3F1 mice. Carcinogenesis. 15(10). 2255–2261. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gordon C. Hard Breakdown of academic impact, for papers by Michael Bartels Breakdown of academic impact, for papers by Wanda M. Haschek Breakdown of academic impact, for papers by Paula A. Oliveira Breakdown of academic impact, for papers by Gary P. Carlson Breakdown of academic impact, for papers by Thomas Nolte Breakdown of academic impact, for papers by John R. Latendresse Breakdown of academic impact, for papers by Walter Pfaller Breakdown of academic impact, for papers by June K. Dunnick Breakdown of academic impact, for papers by Christer Tagesson
Rankless by CCL
2026